COVID-19 symptom-onset to diagnosis and diagnosis to treatment intervals are significant predictors of disease progression and hospitalization in high-risk patients: A real world analysis-Reference-Cited by-同舟云学术

COVID-19 symptom-onset to diagnosis and diagnosis to treatment intervals are significant predictors of disease progression and hospitalization in high-risk patients: A real world analysis

Published:2023-03 Issue:2 Volume:61 Page:220-229
ISSN:2212-5345
Container-title:Respiratory Investigation
language:en
Short-container-title:Respiratory Investigation

Author:

Shimizu Hideyasu^ORCID,Kawase Jin,Hayashi Masamichi,Imaizumi Kazuyoshi,Ito Yuji,Okazawa Mitsushi^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference28 articles.

1. World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern, https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. [accessed 20 August 2022].

2. World Health Organization. COVID-19 Weekly Epidemiological Update, https://apps.who.int/iris/bitstream/handle/10665/352900/nCoV-weekly-sitrep5Apr22-eng.pdf?sequence=1&isAllowed=y. [accessed 20 August 2022].

3. Genomic analysis of SARS-Cov 2 from January to April (in Japanese) https://www.pref.aichi.jp/uploaded/attachment/418084.pdf. [accessed 20 August 2022].

4. Japanese tactics for suppressing COVID-19 spread;Okazawa;Publ Health,2020

5. Health Center Real-time Information-sharing System on COVID-19 (HER-SYS), https://www.mhlw.go.jp/content/10900000/000678061.pdf. [accessed 20 August 2022].

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of early versus late remdesivir treatment in hospitalized mild to moderate COVID-19 patients in the Omicron era: A retrospective study;Medicine;2024-07-19

2. Booster vaccines dose reduced mortality in hospitalized COVID-19 patients requiring oxygen supplementation: Evidence from the Beijing Omicron outbreak;Human Vaccines & Immunotherapeutics;2024-06-21

3. Personalized Assessment of Mortality Risk and Hospital Stay Duration in Hospitalized Patients with COVID-19 Treated with Remdesivir: A Machine Learning Approach;Journal of Clinical Medicine;2024-03-22

4. Molnupiravir for intra-household prevention of COVID-19: The MOVe-AHEAD randomized, placebo-controlled trial;Journal of Infection;2023-11